Cargando…
Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer
The efficacy and toxicity of oxaliplatin-based versus carboplatin/cisplatin-based doublets in patients with previously untreated nonsmall cell lung cancer (NSCLC) have been compared. We searched published randomized controlled trials of oxaliplatin-based or carboplatin/cisplatin-based medications fo...
Autores principales: | Yu, Jing, Xiao, Jing, Yang, Yifan, Cao, Bangwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504603/ https://www.ncbi.nlm.nih.gov/pubmed/26166081 http://dx.doi.org/10.1097/MD.0000000000001072 |
Ejemplares similares
-
Advances in doublet mechanics
por: Ferrari, Mauro, et al.
Publicado: (1997) -
Single pemetrexed is noninferior to platinum-based pemetrexed doublet as first-line treatment on elderly Chinese patients with advanced nonsquamous nonsmall cell lung cancer
por: Pu, Xiaolin, et al.
Publicado: (2017) -
On the $ doublet in $
por: Astner, G, et al.
Publicado: (1970) -
Protocol for Identification and Removal of Doublets with DoubletDecon
por: DePasquale, Erica A.K., et al.
Publicado: (2020) -
The efficacy and safety of osimertinib in treating nonsmall cell lung cancer: A PRISMA-compliant systematic review and meta-analysis
por: Liu, Jing, et al.
Publicado: (2020)